WO2011051968A3 - Compositions pharmaceutiques de carbonate de lanthane et procédé de préparation correspondant - Google Patents

Compositions pharmaceutiques de carbonate de lanthane et procédé de préparation correspondant Download PDF

Info

Publication number
WO2011051968A3
WO2011051968A3 PCT/IN2010/000691 IN2010000691W WO2011051968A3 WO 2011051968 A3 WO2011051968 A3 WO 2011051968A3 IN 2010000691 W IN2010000691 W IN 2010000691W WO 2011051968 A3 WO2011051968 A3 WO 2011051968A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
preparation
lanthanum carbonate
lanthanum
carbonate
Prior art date
Application number
PCT/IN2010/000691
Other languages
English (en)
Other versions
WO2011051968A2 (fr
Inventor
Dhore Aniket
Ranjan Pradhan Manas
V. Sathyanaryana
Rampal Ashok
Original Assignee
Alkem Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alkem Laboratories Ltd. filed Critical Alkem Laboratories Ltd.
Priority to US13/504,082 priority Critical patent/US20120219637A1/en
Priority to AU2010313075A priority patent/AU2010313075A1/en
Publication of WO2011051968A2 publication Critical patent/WO2011051968A2/fr
Publication of WO2011051968A3 publication Critical patent/WO2011051968A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques compactes de carbonate de lanthane comprenant des diluants en quantité comprise entre environ 30 et environ 40% en poids de la composition.
PCT/IN2010/000691 2009-10-26 2010-10-25 Compositions pharmaceutiques de carbonate de lanthane et procédé de préparation correspondant WO2011051968A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/504,082 US20120219637A1 (en) 2009-10-26 2010-10-25 Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof
AU2010313075A AU2010313075A1 (en) 2009-10-26 2010-10-25 Pharmaceutical compositions of lanthanum carbonate and process for the preparation thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2470/MUM/2009 2009-10-26
IN2470MU2009 2009-10-26

Publications (2)

Publication Number Publication Date
WO2011051968A2 WO2011051968A2 (fr) 2011-05-05
WO2011051968A3 true WO2011051968A3 (fr) 2011-06-16

Family

ID=43922728

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2010/000691 WO2011051968A2 (fr) 2009-10-26 2010-10-25 Compositions pharmaceutiques de carbonate de lanthane et procédé de préparation correspondant

Country Status (3)

Country Link
US (1) US20120219637A1 (fr)
AU (1) AU2010313075A1 (fr)
WO (1) WO2011051968A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016051609A1 (fr) * 2014-10-02 2016-04-07 東和薬品株式会社 Médicament comprenant un hydrate de carbonate de lanthane ayant une taille de particules ajustée
JP2016147827A (ja) * 2015-02-12 2016-08-18 株式会社三和化学研究所 炭酸ランタン水和物を含有する医薬製剤
WO2016148263A1 (fr) * 2015-03-19 2016-09-22 第一三共株式会社 Préparation solide contenant un agent antioxydant
JP6630344B2 (ja) 2015-03-19 2020-01-15 第一三共株式会社 着色剤を含有する固形製剤
US10058569B2 (en) * 2015-06-24 2018-08-28 Lupin Limited Lanthanum carbonate compositions
JP6922411B2 (ja) * 2017-05-19 2021-08-18 ニプロ株式会社 炭酸ランタンを含む口腔内崩壊錠
JP2020033303A (ja) * 2018-08-30 2020-03-05 コーアイセイ株式会社 炭酸ランタンを含有する安定な口腔内速崩壊性錠剤
WO2021101461A1 (fr) * 2019-11-21 2021-05-27 Santa Farma İlaç Sanayi̇ A.Ş. Compositions pharmaceutiques solides orales comprenant de l'octahydrate de carbonate de lanthane

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1785141A1 (fr) * 2005-11-09 2007-05-16 Shire International Licensing B.V. Compositions stabilisée de lanthane carbonate
CN101077338A (zh) * 2006-05-24 2007-11-28 天津大学 纳米碳酸镧口腔崩解片及制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2792363B1 (fr) * 2003-08-26 2016-06-29 Shire Biopharmaceuticals Holdings Ireland Limited Formulation pharmaceutique comprenant des composés de lanthane

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1785141A1 (fr) * 2005-11-09 2007-05-16 Shire International Licensing B.V. Compositions stabilisée de lanthane carbonate
CN101077338A (zh) * 2006-05-24 2007-11-28 天津大学 纳米碳酸镧口腔崩解片及制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; AN 2008-L95379 *

Also Published As

Publication number Publication date
AU2010313075A1 (en) 2012-05-31
US20120219637A1 (en) 2012-08-30
WO2011051968A2 (fr) 2011-05-05

Similar Documents

Publication Publication Date Title
WO2011051968A3 (fr) Compositions pharmaceutiques de carbonate de lanthane et procédé de préparation correspondant
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
WO2012042371A3 (fr) Composition pharmaceutique
MX2012001939A (es) Composicion farmaceutica y administraciones de la misma.
WO2008132229A3 (fr) Solutions et compositions hautement concentrées en insuline
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
WO2007141392A3 (fr) Compositions comprenant de l'acide bétulonique
WO2010069532A8 (fr) Anticorps dirigés contre l'angiopoïétine 2 humaine
WO2008122965A3 (fr) Compositions pharmaceutiques à base de cyclosporine
MX2011001782A (es) Composicion farmaceutica y su administracion.
EP2687287A3 (fr) Particules d'administration
EP2687590A3 (fr) Particules d'administration
IL208203A (en) Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
SG10201805198TA (en) 18f - fluciclovine compositions in citrate buffers
MX2011012523A (es) Esteres cetalicos de anhidropentitoles y usos de los mismos.
WO2011069629A3 (fr) Composition pharmaceutique comprenant des oligopeptides
WO2009115084A3 (fr) Nouveaux dérivés de pyrrolopyrimidine et leurs utilisations
WO2010132175A3 (fr) Composition incorporant des huiles émollientes dans un savon liquide pour le corps
WO2010052070A3 (fr) Composition
WO2010049449A3 (fr) Nouveaux sels de sunitinib
WO2012053009A3 (fr) Compositions pharmaceutiques comprenant des agents de décoloration de la peau
TN2009000447A1 (en) An extented-release composition comprising a somatostatin derivative in microparticles
WO2009146202A3 (fr) Compositions trans-cétalisées, synthèse, et applications
WO2010025370A3 (fr) Préparation de ranolazine
WO2011064558A3 (fr) Composition pharmaceutique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10826236

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 13504082

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010313075

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2010313075

Country of ref document: AU

Date of ref document: 20101025

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 10826236

Country of ref document: EP

Kind code of ref document: A2